CIK 0000897448
- Accelerated filer
AMARIN CORP PLC\UK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-04 | THERO JOHN F President and CEO | Sale | −179,327 | $21.15 | $3.8M | 2,158,101 |
| 2019-03-04 | THERO JOHN F President and CEO | Sale | −70,673 | $21.70 | $1.5M | 2,087,428 |
| 2019-03-04 | Ekman Lars Director | Sale | −98,677 | $21.16 | $2.1M | 36,700 |
| 2019-03-04 | Ekman Lars Director | Sale | −36,700 | $21.71 | $797K | 0 |
| 2019-03-01 | Ketchum Steven B Chief Scientific Officer | Sale | −3,503 | $20.94 | $73K | 396,989 |
| 2019-03-01 | Ketchum Steven B Chief Scientific Officer | Sale | −35,398 | $22.10 | $782K | 361,591 |
| 2019-03-01 | Ketchum Steven B Chief Scientific Officer | Sale | −7,099 | $22.64 | $161K | 354,492 |
| 2019-03-01 | Kalb Michael Wayne SVP and CFO | Sale | −7,124 | $20.89 | $149K | 113,427 |
| 2019-03-01 | Kalb Michael Wayne SVP and CFO | Sale | −70,801 | $22.06 | $1.6M | 42,626 |
| 2019-03-01 | Kalb Michael Wayne SVP and CFO | Sale | −22,075 | $22.59 | $499K | 20,551 |
| 2019-02-28 | Ketchum Steven B Chief Scientific Officer | Sale | −9,543 | $20.67 | $197K | 354,492 |
| 2019-02-28 | Kennedy Joseph T General Counsel | Sale | −27,231 | $20.72 | $564K | 31,260 |
| 2019-02-22 | Zakrzewski Joseph S Director | Sale | −180,625 | $19.90 | $3.6M | 84,547 |
| 2019-02-22 | VAN HEEK G JAN Director | Sale | −203,382 | $20.02 | $4.1M | 14,168 |
| 2019-02-22 | Peterson Kristine Director | Sale | −163,500 | $20.02 | $3.3M | 0 |
| 2019-02-22 | Kalb Michael Wayne SVP and CFO | Sale | −50,000 | $18.97 | $949K | 20,551 |
| 2019-02-15 | Kalb Michael Wayne SVP and CFO | Sale | −25,000 | $17.58 | $440K | 20,551 |
| 2019-02-01 | Ketchum Steven B Chief Scientific Officer | Sale | −27,989 | $17.06 | $477K | 354,492 |
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Sale | −9,541 | $17.49 | $167K | 341,297 |
| 2019-01-31 | Kennedy Joseph T General Counsel | Sale | −42,624 | $17.49 | $745K | 31,260 |
Page 3 of 14 · 279 trades